156 related articles for article (PubMed ID: 21037084)
1. Glatiramer acetate attenuates pro-inflammatory T cell responses but does not directly protect neurons from inflammatory cell death.
Herrmann AM; Göbel K; Simon OJ; Melzer N; Schuhmann MK; Stenner MP; Weishaupt A; Kleinschnitz C; Bittner S; Meuth P; Stuve O; Budde T; Kieseier BC; Wiendl H; Meuth SG
Am J Pathol; 2010 Dec; 177(6):3051-60. PubMed ID: 21037084
[TBL] [Abstract][Full Text] [Related]
2. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice.
Aharoni R; Eilam R; Domev H; Labunskay G; Sela M; Arnon R
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19045-50. PubMed ID: 16365293
[TBL] [Abstract][Full Text] [Related]
3. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
Kala M; Rhodes SN; Piao WH; Shi FD; Campagnolo DI; Vollmer TL
Exp Neurol; 2010 Jan; 221(1):136-45. PubMed ID: 19879259
[TBL] [Abstract][Full Text] [Related]
4. Glatiramer acetate treatment directly targets CD11b(+)Ly6G(-) monocytes and enhances the suppression of autoreactive T cells in experimental autoimmune encephalomyelitis.
Toker A; Slaney CY; Bäckström BT; Harper JL
Scand J Immunol; 2011 Sep; 74(3):235-243. PubMed ID: 21595733
[TBL] [Abstract][Full Text] [Related]
5. Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis.
Gentile A; Rossi S; Studer V; Motta C; De Chiara V; Musella A; Sepman H; Fresegna D; Musumeci G; Grasselli G; Haji N; Weiss S; Hayardeny L; Mandolesi G; Centonze D
J Neuroimmune Pharmacol; 2013 Jun; 8(3):651-63. PubMed ID: 23370991
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications.
Arnon R; Aharoni R
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14593-8. PubMed ID: 15371592
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of neuronal L1 cell adhesion molecule expression alleviates inflammatory neuronal injury.
Menzel L; Paterka M; Bittner S; White R; Bobkiewicz W; van Horssen J; Schachner M; Witsch E; Kuhlmann T; Zipp F; Schäfer MK
Acta Neuropathol; 2016 Nov; 132(5):703-720. PubMed ID: 27544757
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of action of glatiramer acetate in multiple sclerosis and beyond.
Aharoni R
Autoimmun Rev; 2013 Mar; 12(5):543-53. PubMed ID: 23051633
[TBL] [Abstract][Full Text] [Related]
9. Astrocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis.
Eilam R; Segal M; Malach R; Sela M; Arnon R; Aharoni R
Glia; 2018 May; 66(5):1098-1117. PubMed ID: 29424049
[TBL] [Abstract][Full Text] [Related]
10. Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role.
Liblau R
J Neurol Sci; 2009 Dec; 287 Suppl 1():S17-23. PubMed ID: 20106343
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis.
Begum-Haque S; Sharma A; Kasper IR; Foureau DM; Mielcarz DW; Haque A; Kasper LH
J Neuroimmunol; 2008 Nov; 204(1-2):58-65. PubMed ID: 18804287
[TBL] [Abstract][Full Text] [Related]
12. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
Aharoni R
J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Glatiramer Acetate Treatment Positively Attenuates Spontaneous Opticospinal Encephalomyelitis.
Koc Ü; Haupeltshofer S; Klöster K; Demir S; Gold R; Faissner S
Cells; 2023 Feb; 12(4):. PubMed ID: 36831209
[No Abstract] [Full Text] [Related]
15. Glatiramer acetate biases dendritic cells towards an anti-inflammatory phenotype by modulating OPN, IL-17, and RORγt responses and by increasing IL-10 production in experimental allergic encephalomyelitis.
Begum-Haque S; Christy M; Wang Y; Kasper E; Ochoa-Reparaz J; Smith JY; Haque A; Kasper LH
J Neuroimmunol; 2013 Jan; 254(1-2):117-24. PubMed ID: 23141166
[TBL] [Abstract][Full Text] [Related]
16. Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis.
Aktas O; Prozorovski T; Smorodchenko A; Savaskan NE; Lauster R; Kloetzel PM; Infante-Duarte C; Brocke S; Zipp F
J Immunol; 2004 Nov; 173(9):5794-800. PubMed ID: 15494532
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis.
Sixt M; Engelhardt B; Pausch F; Hallmann R; Wendler O; Sorokin LM
J Cell Biol; 2001 May; 153(5):933-46. PubMed ID: 11381080
[TBL] [Abstract][Full Text] [Related]
18. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ.
Aharoni R; Kayhan B; Eilam R; Sela M; Arnon R
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14157-62. PubMed ID: 14614135
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation.
Herges K; Millward JM; Hentschel N; Infante-Duarte C; Aktas O; Zipp F
PLoS One; 2011; 6(10):e25456. PubMed ID: 22022398
[TBL] [Abstract][Full Text] [Related]
20. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
